Company intelligence / Profile preview

ALZpath

Carlsbad, California, United Statesalzpath.bio ↗

Ownership: Private
Development stage: Commercial

Overview

ALZpath has developed a proprietary pTau217 antibody that enables highly sensitive and accurate detection of phosphorylated tau 217 in blood. Their blood-based assay is the only commercially available test for pTau217, allowing early diagnosis of Alzheimer’s disease before cognitive symptoms appear. The technology has demonstrated high reliability and scalability in both research and clinical settings, with data presented at major conferences such as AD/PD™ 2025. The test is integrated into leading diagnostic platforms worldwide and has received recognition including a Bronze Edison Award for innovation.

Therapeutic areas: Neurology
Modalities: Antibody (specifically monoclonal antibody for diagnostic use)
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

ALZpathDx

Commercial

Indications: Alzheimer's disease

Partnerships

Bio-Techne CorporationBeckman Coulter DiagnosticsRoche Diagnostics

Beyond the preview

Go deeper on ALZpath.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALZpath.

Explore the full profile